New Zealand at a glance
- Population
- 5.3 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 17.6 % of people, 2025
- Health spending per person
- 5,022 US$ per person, 2024
- Doctors
- 3.61 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
New Zealand Vitamin D Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$7.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $10.1 Mn | — | — |
| 2025 (base) | $10.7 Mn | +$0.6 Mn | — |
| 2026 (forecast) | $11.4 Mn | +$0.7 Mn | +6.2% |
| 2027 (forecast) | $12.1 Mn | +$0.7 Mn | +12.8% |
| 2028 (forecast) | $12.8 Mn | +$0.7 Mn | +19.8% |
| 2029 (forecast) | $13.6 Mn | +$0.8 Mn | +27.2% |
| 2030 (forecast) | $14.5 Mn | +$0.8 Mn | +35.1% |
| 2031 (forecast) | $15.4 Mn | +$0.9 Mn | +43.5% |
| 2032 (forecast) | $16.3 Mn | +$1.0 Mn | +52.4% |
| 2033 (forecast) | $17.3 Mn | +$1.0 Mn | +61.8% |
| 2034 (forecast) | $18.4 Mn | +$1.1 Mn | +71.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $10.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $18.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Test, setting and end user (see all) |
| Key players | Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, DiaSorin, Quest Diagnostics (see all) |
| Regulator in New Zealand | Medsafe (WAND)Source: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Vitamin D tests measure vitamin D levels in blood to find deficiency linked to bone and immune health.
Key segments of the vitamin D Testing market include test (25-Hydroxy Vitamin D and 1,25-Dihydroxy Vitamin D) and setting (Labs, Point of Care and At-Home Kits).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the vitamin D Testing market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the vitamin D Testing market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the vitamin D Testing market.
The vitamin D Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2]
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how vitamin D Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.
What doctors and scientists are doing in Vitamin D Testing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
New Zealand · 2 shared keywords
New Zealand · 2 shared keywords
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
OTC & Nutraceuticals · New Zealand
Digital Health · New Zealand
Healthcare Services · New Zealand
OTC & Nutraceuticals · New Zealand
Healthcare Services · New Zealand
OTC & Nutraceuticals · New Zealand